Cargando…
Nanocarriers for anticancer drugs: Challenges and perspectives
Cancer is the second most common cause of death globally, surpassed only by cardiovascular disease. One of the hallmarks of cancer is uncontrolled cell division and resistance to cell death. Multiple approaches have been developed to tackle this disease, including surgery, radiotherapy and chemother...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130109/ https://www.ncbi.nlm.nih.gov/pubmed/35645591 http://dx.doi.org/10.1016/j.sjbs.2022.103298 |